respiratory disease
AmplifiDx Nabs $954K in RADx Funding for POC Test Instrument Development
The funding will support the development of the AmplifiDx Dx 100 Platform for use with a nucleic acid amplification test for respiratory infections.
At the ADLM annual meeting, firms said they see game-changing opportunities for platforms that provide the right combination of clinical utility and convenience.
The Berlin, Germany-based firm said it plans to expand its test menu to take on many more infectious diseases with its portable molecular instrument.
Abbott, Hologic, Becton Dickinson Secure FDA Clearances in May
The clearances granted in May by the US Food and Drug Administration include a laboratory instrument system, respiratory disease panels, and MRSA detection software.
AmplifiDx Gets $1.4M NIH RADx Grant for Point-of-Care Molecular Testing Instrument
The Massachusetts-based firm plans to use the funding toward development of its nucleic acid amplification test platform and multiplex respiratory test.